In 95/98 (96.9%) patients, visually discernible PSMA-targeted ligand uptake in at least one of the above-indicated peripheral ganglia were identified (96.0% of PCa and 100.0% RCC patients). The gene discussed is FOLH1; the disease is renal cell carcinoma.